Compare OMEX & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OMEX | MLSS |
|---|---|---|
| Founded | 1986 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.7M | 42.6M |
| IPO Year | 2024 | 1996 |
| Metric | OMEX | MLSS |
|---|---|---|
| Price | $0.89 | $0.48 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | ★ 357.7K | 123.4K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $9,327.00 | ★ $8,973,982.00 |
| Revenue This Year | N/A | $12.64 |
| Revenue Next Year | N/A | $8.99 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.99 |
| 52 Week Low | $0.59 | $0.22 |
| 52 Week High | $4.43 | $0.68 |
| Indicator | OMEX | MLSS |
|---|---|---|
| Relative Strength Index (RSI) | 50.84 | 63.36 |
| Support Level | $0.74 | $0.25 |
| Resistance Level | $0.79 | $0.48 |
| Average True Range (ATR) | 0.06 | 0.04 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 83.42 | 87.80 |
Odyssey Marine Exploration Inc is a deep-ocean exploration company. It discovers, validates, and develops high-value seafloor mineral resources and provides specialized mineral exploration, project development, and marine services to its clients. The company's subsea project portfolio contains multiple projects in various stages of development, such as the Phosagmex Project, a rich deposit of phosphate sands located seventy-ninety meters deep within the Mexican EEZ; two polymetallic nodule exploration license holders in the Cook Islands' EEZ; the Lihir Gold Project, a subsea area that contains several prospective gold exploration targets located in the Papua New Guinea Exclusive Economic Zone (EEZ); and others.
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.